The blood-brain barrier in Alzheimer's disease

Neurobiology of Disease

Volumn 107, Issue , 2017, Pages 41-56

  Zenaro, Elena ^a   Piacentino, Gennj ^a   Constantin, Gabriela ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Alzheimer's disease; Blood brain barrier; Immune system cells; Leukocyte trafficking; Neurovascular unit; Vascular inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-42]; BETA SECRETASE 1; CD36 ANTIGEN; CLAUDIN; CLAUDIN 1; CLAUDIN 12; CLAUDIN 3; CLAUDIN 5; FLUORODEOXYGLUCOSE; GELATINASE A; GELATINASE B; GLUCOSE TRANSPORTER 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE B; JUNCTIONAL ADHESION MOLECULE C; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; MYOCARDIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN ZO1; PROTEIN ZO2; REACTIVE OXYGEN METABOLITE; SERUM RESPONSE FACTOR; STROMELYSIN; TAU PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ALZHEIMER DISEASE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME INHIBITION; ERYTHROCYTE; GLIA CELL; HUMAN; IN VITRO STUDY; LEUKOCYTE COUNT; MONOCYTE; NERVOUS SYSTEM FUNCTION; NEUROVASCULAR UNIT; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERICYTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; HUMANS;

EID: 84997079406     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2016.07.007     Document Type: Review

References (265)

1. Abbott, N.J., Rönnbäck, L., Hansson, E., Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7 (2006), 41–53, 10.1038/nrn1824.
2. Abbott, N.J., Patabendige, A.A., Dolman, D.E., Yusof, S.R., Begley, D.J., Structure and function of the blood-brain barrier. Neurobiol. Dis. 37 (2010), 13–25, 10.1016/j.nbd.2009.07.030.
3. Agrawal, S., Anderson, P., Durbeej, M., van Rooijen, N., Ivars, F., Opdenakker, G., Sorokin, L.M., Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 203 (2006), 1007–1019, 10.1084/jem.20051342.
4. Allen, C., Thornton, P., Denes, A., McColl, B.W., Pierozynski, A., Monestier, M., Pinteaux, E., Rothwell, N.J., Allan, S.M., Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J. Immunol. 10 (2012), 381–392, 10.4049/jimmunol.1200409.
5. Alvarez, J.I., Cayrol, R., Prat, A., Disruption of central nervous system barriers in multiple sclerosis. Biochim. Biophys. Acta 1812 (2011), 252–264, 10.1016/j.bbadis.2010.06.017.
6. Angiari, S., Constantin, G., Regulation of T cell trafficking by the T cell immunoglobulin and mucin domain 1 glycoprotein. Trends Mol. Med. 20 (2014), 675–684, 10.1016/j.molmed.2014.10.003.
7. Angiari, S., Donnarumma, T., Rossi, B., Dusi, S., Pietronigro, E., Zenaro, E., Della Bianca, V., Toffali, L., Piacentino, G., Budui, S., Rennert, P., Xiao, S., Laudanna, C., Casasnovas, J.M., Kuchroo, V.K., Constantin, G., TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity 40 (2014), 542–553, 10.1016/j.immuni.2014.03.004.
8. Baik, S.H., Cha, M.Y., Hyun, Y.M., Cho, H., Hamza, B., Kim, D.K., Han, S.H., Choi, H., Kim, K.H., Moon, M., Lee, J., Kim, M., Irimia, D., Mook-Jung, I., Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol. Aging 35 (2014), 1286–1292, 10.1016/j.neurobiolaging.2014.01.003.
9. Barichello, T., Generoso, J.S., Michelon, C.M., Simões, L.R., Elias, S.G., Vuolo, F., Comim, C.M., Dal-Pizzol, F., Quevedo, J., Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats. Exp. Biol. Med. 239 (2014), 225–231, 10.1177/1535370213508354.
10. Baruch, K., Rosenzweig, N., Kertser, A., Deczkowska, A., Sharif, A.M., Spinrad, A., Tsitsou-Kampeli, A., Sarel, A., Cahalon, L., Schwartz, M., Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat. Commun., 6, 2015, 7967, 10.1038/ncomms8967.
11. Bauer, H.C., Traweger, A., Zweimueller-Mayer, J., Lehner, C., Tempfer, H., Krizbai, I., Wilhelm, I., Bauer, H., New aspects of the molecular constituents of tissue barriers. J. Neural Transm. 118 (2011), 7–21, 10.1007/s00702-010-0484-6.
12. Bechmann, I., Galea, I., Perry, V.H., What is the blood-brain barrier (not)?. Trends Immunol. 28 (2007), 5–11.
13. Bednarczyk, J., Lukasiuk, K., Tight junctions in neurological diseases. Acta Neurobiol. Exp. 71 (2011), 393–408.
14. Bell, R.D., Zlokovic, B.V., Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol. 118 (2009), 103–113, 10.1007/s00401-009-0522-3.
15. Bell, R.D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., Streb, J.W., Guo, H., Rubio, A., Van Nostrand, W., Miano, J.M., Zlokovic, B.V., SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat. Cell Biol. 11 (2009), 143–153, 10.1038/ncb1819.
16. Bell, R.D., Winkler, E.A., Sagare, A.P., Singh, I., LaRue, B., Deane, R., Zlokovic, B.V., Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68 (2010), 409–427, 10.1016/j.neuron.2010.09.043.
17. Bell, R.D., Winkler, E.A., Singh, I., Sagare, A.P., Deane, R., Wu, Z., Holtzman, D.M., Betsholtz, C., Armulik, A., Sallstrom, J., Berk, B.C., Zlokovic, B.V., Apolipoprotein E controls cerebrovascular integrity via cyclophilin a. Nature 485 (2012), 512–516, 10.1038/nature11087.
18. Betz, A.L., Goldstein, G.W., Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science 202 (1978), 225–227, 10.1126/science.211586.
19. Blair, L.J., Frauen, H.D., Zhang, B., Nordhues, B.A., Bijan, S., Lin, Y.C., Zamudio, F., Hernandez, L.D., Sabbagh, J.J., Selenica, M.L., Dickey, C.A., Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol. Commun., 3, 2015, 8, 10.1186/s40478-015-0186-2.
20. Block, M.L., NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci., 9(Suppl. 2), 2008, S8, 10.1186/1471-2202-9-S2-S8.
21. Bö, L., Peterson, J.W., Mørk, S., Hoffman, P.A., Gallatin, W.M., Ransohoff, R.M., Trapp, B.D., Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55 (1996), 1060–1072, 10.1097/00005072-199655100-00006.
22. Brightman, M.W., Reese, T.S., Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 40 (1969), 648–677, 10.1083/jcb.40.3.648.
23. Browne, T.C., McQuillan, K., McManus, R.M., O'Reilly, J.A., Mills, K.H., Lynch, M.A., IFN-γ production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. J. Immunol. 190 (2013), 2241–2251, 10.4049/jimmunol.1200947.
24. Buckwalter, M.S., Coleman, B.S., Buttini, M., Barbour, R., Schenk, D., Games, D., Seubert, P., Wyss-Coray, T., Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1. J. Neurosci. 26 (2006), 11437–11441.
25. Cameron, B., Landreth, G.E., Inflammation, microglia, and Alzheimer's disease. Neurobiol. Dis. 37 (2010), 503–509, 10.1016/j.nbd.2009.10.006.
26. Carlos, T.M., Harlan, J.M., Leukocyte-endothelial adhesion molecules. Blood 84 (1994), 2068–2101.
27. Carrano, A., Hoozemans, J.J., van der Vies, S.M., Rozemuller, A.J., van Horssen, J., de Vries, H.E., Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid. Redox Signal. 15 (2011), 1167–1178, 10.1089/ars.2011.3895.
28. Carrano, A., Hoozemans, J.J., van der Vies, S.M., de Vries, H.E., van Horssen, J., Rozemuller, A.J., Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Neurodegener. Dis. 10 (2012), 329–3231, 10.1159/000334916.
29. Cartier, N., Lewis, C.A., Zhang, R., Rossi, F.M., The role of microglia in human disease: therapeutic tool or target?. Acta Neuropathol. 128 (2014), 363–380, 10.1007/s00401-014-1330-y.
30. Caselli, R.J., Beach, T.G., Yaari, R., Reiman, E.M., Alzheimer's disease a century later. J. Clin. Psychiatry 67 (2006), 1784–1800.
31. Chao, A.C., Lee, T.C., Juo, S.H., Yang, D.I., Hyperglycemia increases the production of amyloid beta-peptide leading to decreased endothelial tight junction. CNS Neurosci. Ther. 22 (2016), 291–297, 10.1111/cns.12503.
32. Chiba, H., Osanai, M., Murata, M., Kojima, T., Sawada, N., Transmembrane proteins of tight junctions. Biochim. Biophys. Acta 1778 (2008), 588–600, 10.1016/j.bbamem.2007.08.017.
33. Choi, S.S., Lee, H.J., Lim, I., Satoh, J., Kim, S.U., Human astrocytes: secretome profiles of cytokines and chemokines. PLoS One, 9, 2014, e92325, 10.1371/journal.pone.0092325.
34. Chow, B.W., Gu, C., The molecular constituents of the blood-brain barrier. Trends Neurosci. 38 (2015), 598–608, 10.1016/j.tins.2015.08.003.
35. Chow, N., Bell, R.D., Deane, R., Streb, J.W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J.M., Zlokovic, B.V., Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 823–828, 10.1073/pnas.0608251104.
36. Conductier, G., Blondeau, N., Guyon, A., Nahon, J.L., Rovère, C., The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J. Neuroimmunol. 224 (2010), 93–100, 10.1016/j.jneuroim.2010.05.010.
37. Corada, M., Mariotti, M., Thurston, G., Smith, K., Kunkel, R., Brockhaus, M., Lampugnani, M.G., Martin-Padura, I., Stoppacciaro, A., Ruco, L., McDonald, D.M., Ward, P.A., Dejana, E., Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 9815–9820, 10.1073/pnas.96.17.9815.
38. Cortes-Canteli, M., Paul, J., Norris, E.H., Bronstein, R., Ahn, H.J., Zamolodchikov, D., Bhuvanendran, S., Fenz, K.M., Strickland, S., Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron 66 (2010), 695–709, 10.1016/j.neuron.2010.05.014.
39. Cumming, J.L., Alzheimer's disease. N. Engl. J. Med. 351 (2004), 56–67, 10.1056/NEJMra040223.
40. da Fonseca, A.C., Matias, D., Garcia, C., Amaral, R., Geraldo, L.H., Freitas, C., Lima, F.R., The impact of microglial activation on blood-brain barrier in brain diseases. Front. Cell. Neurosci., 8, 2014, 362, 10.3389/fncel.2014.00362.
41. Daneman, R., Prat, A., The blood-brain barrier. Cold Spring Harb. Perspect. Biol., 7, 2015, a020412, 10.1101/cshperspect.a020412.
42. Daneman, R., Zhou, L., Kebede, A.A., Barres, B.A., Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468 (2010), 562–566, 10.1038/nature09513.
43. Dansokho, C., Ait Ahmed, D., Aid, S., Toly-Ndour, C., Chaigneau, T., Calle, V., Cagnard, N., Holzenberger, M., Piaggio, E., Aucouturier, P., Dorothée, G., Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 139 (2016), 1237–1251, 10.1093/brain/awv408 (Apr).
44. Davalos, D., Ryu, J.K., Merlini, M., Baeten, K.M., Le Moan, N., Petersen, M.A., Deerinck, T.J., Smirnoff, D.S., Bedard, C., Hakozaki, H., Gonias Murray, S., Ling, J.B., Lassmann, H., Degen, J.L., Ellisman, M.H., Akassoglou, K., Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun., 3, 2012, 1227, 10.1038/ncomms2230.
45. de la Torre, J.C., Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 3 (2004), 184–190, 10.1016/S1474-4422(04)00683-0.
46. Deane, R., Zlokovic, B.V., Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 4 (2007), 191–197, 10.2174/156720507780362245.
47. Deane, R., Wu, Z., Zlokovic, B.V., RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35 (2004), 2628–2631, 10.1161/01.str.0000143452.85382.d1.
48. Deane, R., Singh, I., Sagare, A.P., Bell, R.D., Ross, N.T., LaRue, B., Love, R., Perry, S., Paquette, N., Deane, R.J., Thiyagarajan, M., Zarcone, T., Fritz, G., Friedman, A.E., Miller, B.L., Zlokovic, B.V., A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122 (2012), 1377–1392, 10.1172/JCI58642.
49. Del Maschio, A., De Luigi, A., Martin-Padura, I., Brockhaus, M., Bartfai, T., Fruscella, P., Adorini, L., Martino, G., Furlan, R., De Simoni, M.G., Dejana, E., Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J. Exp. Med. 190 (1999), 1351–1356, 10.1084/jem.190.9.1351.
50. Demeule, M., Labelle, M., Régina, A., Berthelet, F., Béliveau, R., Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms. Biochem. Biophys. Res. Commun. 281 (2001), 827–834, 10.1006/bbrc.2001.4312.
51. Deshmane, S.L., Kremlev, S., Amini, S., Sawaya, B.E., Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interf. Cytokine Res. 29 (2009), 313–326, 10.1089/jir.2008.0027.
52. Devraj, K., Poznanovic, S., Spahn, C., Schwall, G., Harter, P.N., Mittelbronn, M., Antoniello, K., Paganetti, P., Muhs, A., Heilemann, M., Hawkins, R.A., Schrattenholz, A., Liebner, S., BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's disease. J. Cereb. Blood Flow Metab., 2015 (pii: 0271678X15606463. [Epub ahead of print]).
53. DiStasi, M.R., Ley, K., Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol. 30 (2009), 547–556, 10.1016/j.it.2009.07.012.
54. Donahue, J.E., Flaherty, S.L., Johanson, C.E., Duncan, J. 3rd., Silverberg, G.D., Miller, M.C., Tavares, R., Yang, W., Wu, Q., Sabo, E., Hovanesian, V., Stopa, E.G., RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 112 (2006), 405–415, 10.1007/s00401-006-0115-3.
55. Dore-Duffy, P., Pericytes: pluripotent cells of the blood brain barrier. Curr. Pharm. Des. 14 (2008), 1581–1593, 10.2174/138161208784705469.
56. Du, H., Li, P., Wang, J., Qing, X., Li, W., The interaction of amyloid β and the receptor for advanced glycation endproducts induces matrix metalloproteinase-2 expression in brain endothelial cells. Cell. Mol. Neurobiol. 32 (2012), 141–147, 10.1007/s10571-011-9744-8 (Jan).
57. El Khoury, J., Toft, M., Hickman, S.E., Means, T.K., Terada, K., Geula, C., Luster, A.D., Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13 (2007), 432–438, 10.1038/nm1555.
58. ElAli, A., Thériault, P., Rivest, S., The role of pericytes in neurovascular unit remodeling in brain disorders. Int. J. Mol. Sci. 15 (2014), 6453–6574, 10.3390/ijms15046453.
59. Engelhardt, B., Ransohoff, R.M., The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 26 (2005), 485–495, 10.1016/j.it.2005.07.004.
60. Engelhardt, B., Sorokin, L., The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 31 (2009), 497–511, 10.1007/s00281-009-0177-0 (Nov).
61. Erickson, M.A., Banks, W.A., Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J. Cereb. Blood Flow Metab. 33 (2013), 1500–1513, 10.1038/jcbfm.2013.135.
62. Fabene, P.F., Navarro Mora, G., Martinello, M., Rossi, B., Merigo, F., Ottoboni, L., Bach, S., Angiari, S., Benati, D., Chakir, A., Zanetti, L., Schio, F., Osculati, A., Marzola, P., Nicolato, E., Homeister, J.W., Xia, L., Lowe, J.B., McEver, R.P., Osculati, F., Sbarbati, A., Butcher, E.C., Constantin, G., A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 14 (2008), 1377–1383, 10.1038/nm.1878.
63. Fanning, A.S., Jameson, B.J., Jesaitis, L.A., Anderson, J.M., The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 273 (1998), 29745–29753.
64. Farach-Carson, M.C., Warren, C.R., Harrington, D.A., Carson, D.D., Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders. Matrix Biol. 34 (2014), 64–79, 10.1016/j.matbio.2013.08.004.
65. Farkas, E., Luiten, P.G., Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64 (2001), 575–611, 10.1016/S0301-0082(00)00068-X.
66. Farrall, A.J., Wardlaw, J.M., Blood-brain barrier: ageing and microvascular disease–systematic review and meta-analysis. Neurobiol. Aging 30 (2009), 337–352, 10.1016/j.neurobiolaging.2007.07.015.
67. Feng, Y., Wang, X., Antioxidant therapies for Alzheimer's disease. Oxidative Med. Cell. Longev., 2012, 2012, 472932, 10.1155/2012/472932.
68. Ferretti, M.T., Merlini, M., Späni, C., Gericke, C., Schweizer, N., Enzmann, G., Engelhardt, B., Kulic, L., Suter, T., Nitsch, R.M., T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis. Brain Behav. Immun. 54 (2016), 30030–30070, 10.1016/j.bbi.2016.02.009.
69. Fiala, M., Zhang, L., Gan, X., Sherry, B., Taub, D., Graves, M.C., Hama, S., Way, D., Weinand, M., Witte, M., Lorton, D., Kuo, Y.M., Roher, A.E., Amyloid-beta induces chemokine secretion and monocyte migration across a human blood–brain barrier model. Mol. Med. 4 (1998), 480–489.
70. Forman, M.S., Lal, D., Zhang, B., Dabir, D.V., Swanson, E., Lee, V.M., Trojanowski, J.Q., Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J. Neurosci. 25 (2005), 3539–3550, 10.1523/jneurosci.0081-05.2005.
71. Förster, C., Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 130 (2008), 55–70, 10.1007/s00418-008-0424-9.
72. Frey, R.S., Ushio-Fukai, M., Malik, A.B., NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid. Redox Signal. 4 (2009), 791–810, 10.1089/ARS.2008.2220.
73. Frohman, E.M., Frohman, T.C., Gupt, S., de Fougerolles, A., van den Noort, S., Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease. J. Neurol. Sci. 106 (1991), 105–111, 10.1016/0022-510X(91)90202-I.
74. Fu, R., Shen, Q., Xu, P., Luo, J.J., Tang, Y., Phagocytosis of microglia in the central nervous system diseases. Mol. Neurobiol. 49 (2014), 1422–1434, 10.1007/s12035-013-8620-6.
75. Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., Tsukita, S., Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123 (1993), 1777–1788, 10.1083/jcb.123.6.1777.
76. Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M.A., Bresolin, N., Scarpini, E., Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch. Neurol. 63 (2006), 538–543, 10.1001/archneur.63.4.538.
77. Galimberti, D., Fenoglio, C., Scarpini, E., Inflammation in neurodegenerative disorders: friend or foe?. Curr. Aging Sci. 1 (2008), 30–41, 10.2174/1874609810801010030.
78. Garrido-Urbani, S., Bradfield, P.F., Imhof, B.A., Tight junction dynamics: the role of junctional adhesion molecules (JAMs). Cell Tissue Res. 355 (2014), 701–715, 10.1007/s00441-014-1820-1.
79. Garton, K.J., Gough, P.J., Raines, E.W., Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J. Leukoc. Biol. 79 (2006), 1105–1116, 10.1189/jlb.0106038.
80. Giri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A.M., Stern, D., Kim, K.S., Zlokovic, B., Kalra, V.K., Beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 279 (2000), C1772–C1781.
81. Giri, R., Selvaraj, S., Miller, C.A., Hofman, F., Yan, S.D., Stern, D., Zlokovic, B.V., Kalra, V.K., Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. Am. J. Physiol. Cell Physiol. 283 (2002), C895–C904.
82. Gonçalves, A., Ambrósio, A.F., Fernandes, R., Regulation of claudins in blood-tissue barriers under physiological and pathological states. Tissue Barriers, 1, 2013, e24782, 10.4161/tisb.24782.
83. Gorina, R., Lyck, R., Vestweber, D., Engelhardt, B., β2 integrin-mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood-brain barrier. J. Immunol. 192 (2014), 324–337, 10.4049/jimmunol.1300858.
84. Gotsch, U., Borges, E., Bosse, R., Böggemeyer, E., Simon, M., Mossmann, H., Vestweber, D., VE-cadherin antibody accelerates neutrophil recruitment in vivo. J. Cell Sci. 110 (1997), 583–588.
85. Graesser, D., Mahooti, S., Haas, T., Davis, S., Clark, R.B., Madri, J.A., The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab. Investig. 78 (1998), 1445–1458.
86. Grammas, P., Ovase, R., et al. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol. Aging 22 (2001), 837–842, 10.1016/s0197-4580(01)00276-7.
87. Grammas, P., Martinez, J., Miller, B., Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev. Mol. Med., 13, 2011, e19, 10.1017/S1462399411001918.
88. Guillemin, G.J., Brew, B.J., Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75 (2004), 388–397, 10.1189/jlb.0303114.
89. Guo, Y.X., He, L.Y., Zhang, M., Wang, F., Liu, F., Peng, W.X., 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport. Neuroscience 322 (2016), 28–38, 10.1016/j.neuroscience.2016.01.041.
90. Gurney, K.J., Estrada, E.Y., Rosenberg, G.A., Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol. Dis. 23 (2006), 87–96, 10.1016/j.nbd.2006.02.006.
91. Halliday, M.R., Rege, S.V., Ma, Q., Zhao, Z., Miller, C.A., Winkler, E.A., Zlokovic, B.V., Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. J. Cereb. Blood Flow Metab. 36 (2016), 216–227, 10.1038/jcbfm.2015.44.
92. Hallmann, R., Horn, N., Selg, M., Wendler, O., Pausch, F., Sorokin, L.M., Expression and function of laminins in the embryonic and mature vasculature. Physiol. Rev. 85 (2005), 979–1000, 10.1152/physrev.00014.2004.
93. Hanisch, U.K., Functional diversity of microglia - how heterogeneous are they to begin with?. Front. Cell. Neurosci., 7, 2013, 65, 10.3389/fncel.2013.00065.
94. Harry, G.J., Microglia during development and aging. Pharmacol. Ther. 139 (2013), 313–326, 10.1016/j.pharmthera.
95. Hawkes, C.A., McLaurin, J., Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 1261–1266, 10.1073/pnas.0805453106.
96. Hawkins, B.T., Davis, T.P., The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57 (2005), 173–185, 10.1124/pr.57.2.4.
97. Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M., Herrup, K., Frautschy, S.A., Finsen, B., Brown, G.C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G.C., Town, T., Morgan, D., Shinohara, M.L., Perry, V.H., Holmes, C., Bazan, N.G., Brooks, D.J., Hunot, S., Joseph, B., Deigendesch, N., Garaschuk, O., Boddeke, E., Dinarello, C.A., Breitner, J.C., Cole, G.M., Golenbock, D.T., Kummer, M.P., Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14 (2015), 388–405, 10.1016/S1474-4422(15)70016-5.
98. Hickman, S.E., Allison, E.K., El Khoury, J., Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28 (2008), 8354–8560, 10.1523/JNEUROSCI.0616-08.2008.
99. Hill, J., Rom, S., Ramirez, S.H., Persidsky, Y., Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease. J. NeuroImmune Pharmacol. 9 (2014), 591–605, 10.1007/s11481-014-9557-x.
100. Hooijmans, C.R., Graven, C., Dederen, P.J., Tanila, H., van Groen, T., Kiliaan, A.J., Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res. 1181 (2007), 93–103.
101. Hoshi, A., Yamamoto, T., Shimizu, K., Ugawa, Y., Nishizawa, M., Takahashi, H., Kakita, A., Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease. J. Neuropathol. Exp. Neurol. 71 (2012), 750–759, 10.1097/NEN.0b013e3182632566.
102. Hu, Q., Chen, C., Yan, J., Yang, X., Shi, X., Zhao, J., Lei, J., Yang, L., Wang, K., Chen, L., Huang, H., Han, J., Zhang, J.H., Zhou, C., Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model. Exp. Neurol. 216 (2009), 35–46, 10.1016/j.expneurol.2008.11.007.
103. Huang, C.W., Tsai, M.H., Chen, N.C., Chen, W.H., Lu, Y.T., Lui, C.C., Chang, Y.T., Chang, W.N., Chang, A.Y., Chang, C.C., Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia. Thromb. Haemost. 114 (2015), 1230–1240, 10.1160/TH14-11-0938.
104. Hudson, L.C., Bragg, D.C., Tompkins, M.B., Meeker, R.B., Astrocytes and microglia differentially regulate trafficking of lymphocyte subsets across brain endothelial cells. Brain Res. 1058 (2005), 148–160, 10.1016/j.brainres.2005.07.071.
105. Hunt, A., Schönknecht, P., Henze, M., Seidl, U., Haberkorn, U., Schröder, J., Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiatry Res. 155 (2007), 147–154, 10.1016/j.pscychresns.2006.12.003.
106. Iadecola, C., Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat. Rev. Neurosci. 5 (2004), 347–360, 10.1038/nrn1387.
107. Iliff, J.J., Wang, M., Liao, Y., Plogg, B.A., Peng, W., Gundersen, G.A., Benveniste, H., Vates, G.E., Deane, R., Goldman, S.A., Nagelhus, E.A., Nedergaard, M., A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med., 4, 2012, 147ra111, 10.1126/scitranslmed.3003748.
108. Ishizuka, K., Kimura, T., Igata-yi, R., Katsuragi, S., Takamatsu, J., Miyakawa, T., Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin. Neurosci. 51 (1997), 135–138, 10.1111/j.1440-1819.1997.tb02375.x.
109. Itagaki, S., McGeer, P.L., Akiyama, H., Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci. Lett. 91 (1988), 259–264, 10.1016/0304-3940(88)90690-8.
110. Jander, S., Pohl, J., Gillen, C., Schroeter, M., Stoll, G., Vascular cell adhesion molecule-1 mRNA is expressed in immune-mediated and ischemic injury of the rat nervous system. J. Neuroimmunol. 70 (1996), 75–80, 10.1016/S0165-5728(96)00109-9.
111. Järemo, P., Milovanovic, M., Buller, C., Nilsson, S., Winblad, B., P-selectin paradox and dementia of the Alzheimer type: circulating P-selectin is increased but platelet-bound P-selectin after agonist provocation is compromised. Scand. J. Clin. Lab. Invest. 73 (2013), 170–174, 10.3109/00365513.2013.764572.
112. Jellinger, K.A., Alzheimer disease and cerebrovascular pathology: an update. J. Neural Transm. 109 (2002), 813–836, 10.1007/s007020200068.
113. Jolivel, V., Bicker, F., Binamé, F., Ploen, R., Keller, S., Gollan, R., Jurek, B., Birkenstock, J., Poisa-Beiro, L., Bruttger, J., Opitz, V., Thal, S.C., Waisman, A., Bäuerle, T., Schäfer, M.K., Zipp, F., Schmidt, M.H., Perivascular microglia promote blood vessel disintegration in the ischemic penumbra. Acta Neuropathol. 129 (2015), 279–295, 10.1007/s00401-014-1372-1.
114. Kalaria, R.N., The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging 21 (2000), 321–330, 10.1016/S0197-4580(00)00125-1.
115. Kalaria, R.N., Harik, S.I., Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem. 53 (1989), 1083–1088, 10.1111/j.1471-4159.1989.tb07399.x.
116. Kalaria, R.N., Hedera, P., Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6 (1995), 477–480, 10.1097/00001756-199502000-00018.
117. Kang, Z., Altuntas, C.Z., Gulen, M.F., Liu, C., Giltiay, N., Qin, H., Liu, L., Qian, W., Ransohoff, R.M., Bergmann, C., Stohlman, S., Tuohy, V.K., Li, X., Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32 (2010), 414–425, 10.1016/j.immuni.2010.03.004.
118. Karpus, W.J., Lukacs, N.W., McRae, B.L., Strieter, R.M., Kunkel, S.L., Miller, S.D., An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155 (1995), 5003–5010.
119. Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., Prat, A., Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13 (2007), 1173–1175.
120. Kidd, M., Paired helical filaments in electron microscopy of Alzheimer's disease. Nature 197 (1963), 192–193, 10.1038/197192b0.
121. Kivisäkk, P., Mahad, D.J., Callahan, M.K., Trebst, C., Tucky, B., Wei, T., Wu, L., Baekkevold, E.S., Lassmann, H., Staugaitis, S.M., Campbell, J.J., Ransohoff, R.M., Human cerebrospinal fluid central memory CD4 + T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 8389–8394, 10.1073/pnas.1433000100.
122. 2 ⁺-calcineurin signaling. J. Neurosci. 32 (2012), 8845–8854, 10.1523/JNEUROSCI.6102-11.2012.
123. Kovac, A., Zilkova, M., Deli, M.A., Zilka, N., Novak, M., Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier. J. Alzheimers Dis. 18 (2009), 897–906, 10.3233/JAD-2009-1197.
124. Krabbe, G., Halle, A., Matyash, V., Rinnenthal, J.L., Eom, G.D., Bernhardt, U., Miller, K.R., Prokop, S., Kettenmann, H., Heppner, F.L., Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology. PLoS One, 8, 2013, e60921, 10.1371/journal.pone.0060921.
125. Kuhnke, D., Jedlitschky, G., Grube, M., Krohn, M., Jucker, M., Mosyagin, I., Cascorbi, I., Walker, L.C., Kroemer, H.K., Warzok, R.W., Vogelgesang, S., MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides–implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol. 17 (2007), 347–353, 10.1111/j.1750-3639.2007.00075.x.
126. Lam, F.C., Liu, R., Lu, P., Shapiro, A.B., Renoir, J.M., Sharom, F.J., Reiner, P.B., Beta-amyloid efflux mediated by p-glycoprotein. J. Neurochem. 76 (2001), 1121–1128, 10.1046/j.1471-4159.2001.00113.x.
127. Lécuyer, M.A., Kebir, H., Prat, A., Glial influences on BBB functions and molecular players in immune cell trafficking. Biochim. Biophys. Acta 1862 (2016), 472–482, 10.1016/j.bbadis.2015.10.004.
128. Lepelletier, F.X., Mann, D.M., Robinson, A.C., Pinteaux, E., Boutin, H., Early changes in extracellular matrix in Alzheimer's disease. Neuropathol. Appl. Neurobiol., 2015, 10.1111/nan.12295 (Epub ahead of print).
129. Ley, K., The role of selectins in inflammation and disease. Trends Mol. Med. 9 (2003), 263–268.
130. Ley, K., Laudanna, C., Cybulsky, M.I., Nourshargh, S., Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7 (2007), 678–689, 10.1038/nri2156.
131. Li, J.-P., Vlodavsky, I., Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb. Haemost. 102 (2009), 823–828, 10.1160/TH09-02-0091.
132. Li, M., Shang, D.S., Zhao, W.D., Tian, L., Li, B., Fang, W.G., Zhu, L., Man, S.M., Chen, Y.H., Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J. Immunol. 182 (2009), 5778–5788, 10.4049/jimmunol.0803013.
133. Li, G., Xiong, K., Korff, A., Pan, C., Quinn, J.F., Galasko, D.R., Liu, C., Montine, T.J., Peskind, E.R., Zhang, J., Increased CSF E-selectin in clinical Alzheimer's disease without altered CSF Aβ42 and tau. J. Alzheimers Dis. 47 (2015), 883–887, 10.3233/JAD-150420.
134. Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.H., Kalbacher, H., Wolburg, H., Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 100 (2000), 323–331, 10.1007/s004010000180.
135. Liu, Y.J., Guo, D.W., Tian, L., Shang, D.S., Zhao, W.D., Li, B., Fang, W.G., Zhu, L., Chen, Y.H., Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent. Neurobiol. Aging 31 (2010), 175–188, 10.1016/j.neurobiolaging.2008.03.024.
136. Lo, S.K., Lee, S., Ramos, R.A., Lobb, R., Rosa, M., Chi-Rosso, G., Wright, S.D., Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils. J. Exp. Med. 173 (1991), 1493–1500.
137. Lok, J., Gupta, P., Guo, S., Kim, W.J., Whalen, M.J., van Leyen, K., Lo, E.H., Cell-cell signaling in the neurovascular unit. Neurochem. Res. 32 (2007), 2032–2045, 10.1016/S0197-4580(00)00125-1.
138. Löscher, W., Potschka, H., Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog. Neurobiol. 76 (2005), 22–76, 10.1038/nrn1728.
139. Lueg, G., Gross, C.C., Lohmann, H., Johnen, A., Kemmling, A., Deppe, M., Groger, J., Minnerup, J., Wiendl, H., Meuth, S.G., Duning, T., Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease. Neurobiol. Aging 36 (2015), 81–89, 10.1016/j.neurobiolaging.2014.08.008.
140. Malm, T., Koistinaho, M., Muona, A., Magga, J., Koistinaho, J., The role and therapeutic potential of monocytic cells in Alzheimer's disease. Glia 58 (2010), 889–900, 10.1002/glia.20973.
141. Man, S.M., Ma, Y.R., Shang, D.S., Zhao, W.D., Li, B., Guo, D.W., Fang, W.G., Zhu, L., Chen, Y.H., Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol. Aging 28 (2007), 485–496, 10.1016/j.neurobiolaging.2006.02.013.
142. Marco, S., Skaper, S.D., Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci. Lett. 401 (2006), 219–224, 10.1016/j.neulet.2006.03.047.
143. McManus, R.M., Higgins, S.C., Mills, K.H., Lynch, M.A., Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice. Neurobiol. Aging 35 (2014), 109–121, 10.1016/j.neurobiolaging.2013.07.025.
144. Mennicken, F., Maki, R., de Souza, E.B., Quirion, R., Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20 (1999), 73–78.
145. Merlini, M., Meyer, E.P., Ulmann-Schuler, A., Nitsch, R.M., Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Acta Neuropathol. 122 (2011), 293–311, 10.1007/s00401-011-0834-y.
146. Michaud, J.P., Bellavance, M.A., Préfontaine, P., Rivest, S., Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta. Cell Rep. 5 (2013), 646–653, 10.1016/j.celrep.2013.10.010.
147. Mo, R., Chen, J., Han, Y., Bueno-Cannizares, C., Misek, D.E., Lescure, P.A., Hanash, S., Yung, R.L., T cell chemokine receptor expression in aging. J. Immunol. 170 (2003), 895–904.
148. Montagne, A., Barnes, S.R., Sweeney, M.D., Halliday, M.R., Sagare, A.P., Zhao, Z., Toga, A.W., Jacobs, R.E., Liu, C.Y., Amezcua, L., Harrington, M.G., Chui, H.C., Law, M., Zlokovic, B.V., Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85 (2015), 296–302, 10.1016/j.neuron.2014.12.032.
149. Mooradian, A.D., Chung, H.C., Shah, G.N., GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol. Aging 18 (1997), 469–474, 10.1016/S0197-4580(97)00111-5.
150. Morita, K., Sasaki, H., Furuse, M., Tsukita, S., Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147 (1999), 1185–1194, 10.1083/jcb.147.1.185.
151. Mosconi, L., Tsui, W.H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E.M., Holthoff, V., Kalbe, E., Sorbi, S., Diehl-Schmid, J., Perneczky, R., Clerici, F., Caselli, R., Beuthien-Baumann, B., Kurz, A., Minoshima, S., de Leon, M.J., Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J. Nucl. Med. 49 (2008), 390–398, 10.2967/jnumed.107.045385.
152. Muller, W.A., Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24 (2003), 327–334, 10.1016/S1471-4906(03)00117-0.
153. Muradashvili, N., Tyagi, R., Metreveli, N., Tyagi, S.C., Lominadze, D., Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia. J. Cereb. Blood Flow Metab. 34 (2014), 1472–1482, 10.1038/jcbfm.2014.102.
154. Naert, G., Rivest, S., CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 31 (2011), 6208–6220, 10.1523/JNEUROSCI.0299-11.2011.
155. Naert, G., Rivest, S., Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)/PS1 mice. Front. Cell. Neurosci., 6, 2012, 51, 10.3389/fncel.2012.00051.
156. Naert, G., Rivest, S., A deficiency in CCR2 + monocytes: the hidden side of Alzheimer's disease. J. Mol. Cell Biol. 5 (2013), 284–293, 10.1093/jmcb/mjt028.
157. Naik, P., Fofaria, N., Prasad, S., Sajja, R.K., Weksler, B., Couraud, P.O., Romero, I.A., Cucullo, L., Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe?. BMC Neurosci., 15, 2014, 51, 10.1186/1471-2202-15-51.
158. Neuwelt, E., Abbott, N.J., Abrey, L., Banks, W.A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., Pardridge, W., Rosenberg, G.A., Smith, Q., Drewes, L.R., Strategies to advance translational research into brain barriers. Lancet Neurol. 7 (2008), 84–96, 10.1016/S1474-4422(07)70326-5.
159. Newman, W., Beall, L.D., Carson, C.W., Hunder, G.G., Graben, N., Randhawa, Z.I., Gopal, T.V., Wiener-Kronish, J., Matthay, M.A., Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J. Immunol. 150 (1993), 644–654.
160. Nielsen, H.M., Londos, E., Minthon, L., Janciauskiene, S.M., Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiol. Dis. 26 (2007), 27–35, 10.1016/j.nbd.2006.11.011.
161. Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., Tsukita, S., Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161 (2003), 653–660, 10.1083/jcb.200302070.
162. Noble, L.J., Donovan, F., Igarashi, T., Goussev, S., Werb, Z., Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J. Neurosci. 22 (2002), 7526–7535.
163. Opdenakker, G., Van den Steen, P.E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., Van Damme, J., Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69 (2001), 851–859.
164. Ostermann, G., Weber, K.S., Zernecke, A., Schröder, A., Weber, C., JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat. Immunol. 3 (2002), 151–158, 10.1038/ni755.
165. Pappenheimer, J.R., Renkin, E.M., Borrero, L.M., Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability. Am. J. Phys. 167 (1951), 13–46.
166. Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G.A., Iadecola, C., NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J. Neurosci. 25 (2005), 1769–1777, 10.1523/JNEUROSCI.5207-04.2005.
167. Park, L., Kook, S.Y., Park, J.C., Mook-Jung, I., Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling. Cell Death Dis., 5, 2014, e1299, 10.1038/cddis.2014.258.
168. Paul, J., et al. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J. Exp. Med. 204 (2007), 1999–2008, 10.1084/jem.20070304.
169. Peppiatt, C.M., Howarth, C., Mobbs, P., Attwell, D., Bidirectional control of CNS capillary diameter by pericytes. Nature 443 (2006), 700–704, 10.1038/nature05193.
170. Persidsky, Y., Ghorpade, A., Rasmussen, J., Limoges, J., Liu, X.J., Stins, M., Fiala, M., Way, D., Kim, K.S., Witte, M.H., Weinand, M., Carhart, L., Gendelman, H.E., Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155 (1999), 1599–1611, 10.3109/13550289909021287.
171. Persidsky, Y., Ramirez, S.H., Haorah, J., Kanmogne, G.D., Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. NeuroImmune Pharmacol. 1 (2006), 223–236, 10.1007/s11481-006-9025-3.
172. Petty, M.A., Lo, E.H., Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 68 (2002), 311–323, 10.1016/S0301-0082(02)00128-4.
173. Pflanzner, T., Kuhlmann, C.R., Pietrzik, C.U., Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease. Curr. Alzheimer Res. 7 (2010), 578–590, 10.2174/156720510793499066.
174. Pietronigro, E., Zenaro, E., Constantin, G., Imaging of leukocyte trafficking in Alzheimer's disease. Front. Immunol., 7, 2016, 33, 10.3389/fimmu.2016.00033.
175. Pimentel-Coelho, P.M., Michaud, J.P., Rivest, S., C-C chemokine receptor type 2 (CCR2) signaling protects neonatal male mice with hypoxic-ischemic hippocampal damage from developing spatial learning deficits. Behav. Brain Res. 286 (2015), 146–151, 10.1016/j.bbr.2015.02.053.
176. Proebstl, D., Voisin, M.B., Woodfin, A., Whiteford, J., D'Acquisto, F., Jones, G.E., Rowe, D., Nourshargh, S., Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J. Exp. Med. 209 (2012), 1219–1234, 10.1084/jem.20111622.
177. Prokop, S., Miller, K.R., Drost, N., Handrick, S., Mathur, V., Luo, J., Wegner, A., Wyss-Coray, T., Heppner, F.L., Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice. J. Exp. Med. 212 (2015), 1811–1818, 10.1084/jem.20150479.
178. Qiu, L.B., Zhou, Y., Wang, Q., Yang, L.L., Liu, H.Q., Xu, S.L., Qi, Y.H., Ding, G.R., Guo, G.Z., Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats. Toxicology 285 (2011), 31–38, 10.1016/j.tox.2011.03.019.
179. Quan, N., Banks, W.A., Brain-immune communication pathways. Brain Behav. Immun. 21 (2007), 727–735, 10.1016/j.bbi.2007.05.005.
180. Querfurth, H.W., LaFerla, F.M., Alzheimer's disease. N. Engl. J. Med. 362 (2010), 329–344, 10.1056/NEJMra0909142.
181. Ransohoff, R.M., Engelhardt, B., The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12 (2012), 623–635, 10.1038/nri3265.
182. Ransohoff, R.M., Kivisäkk, P., Kidd, G., Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3 (2003), 569–581, 10.1038/nri1130.
183. Reichel, C.A., Rehberg, M., Bihari, P., Moser, C.M., Linder, S., Khandoga, A., Krombach, F., Gelatinases mediate neutrophil recruitment in vivo: evidence for stimulus specificity and a critical role in collagen IV remodeling. J. Leukoc. Biol. 83 (2008), 864–874, 10.1189/jlb.1007666.
184. Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., Vassilopoulos, D., The role of soluble intercellular adhesion molecules in neurodegenerative disorders. J. Neurol. Sci. 228 (2005), 129–135.
185. Roebuck, K.A., Finnegan, A., Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol. 66 (1999), 876–888.
186. Rogers, J., Luber-Narod, J., Styren, S.D., Civin, W.H., Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 9 (1988), 339–349, 10.1016/S0197-4580(88)80079-4.
187. Roher, A.E., Kuo, Y.M., Esh, C., Knebel, C., Weiss, N., Kalback, W., Luehrs, D.C., Childress, J.L., Beach, T.G., Weller, R.O., Kokjohn, T.A., Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol. Med. 9 (2003), 112–122, 10.3389/fnagi.2015.00200.
188. Rossi, B., Angiari, S., Zenaro, E., Budui, S.L., Constantin, G., Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J. Leukoc. Biol. 89 (2011), 539–556, 10.1189/jlb.0710432.
189. Ryu, J.K., McLarnon, J.G., A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J. Cell. Mol. Med. 13 (2009), 2911–2925, 10.1111/j.1582-4934.2008.00434.x.
190. Sagare, A.P., Bell, R.D., Zlokovic, B.V., Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Cold Spring Harb. Perspect. Med., 2, 2012, 10.1101/cshperspect.a011452.
191. Sagare, A.P., Bell, R.D., Zhao, Z., Ma, Q., Winkler, E.A., Ramanathan, A., Zlokovic, B.V., Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat. Commun., 4, 2013, 2932, 10.1038/ncomms3932.
192. Samuraki, M., Matsunari, I., Chen, W.P., Yajima, K., Yanase, D., Fujikawa, A., Takeda, N., Nishimura, S., Matsuda, H., Yamada, M., Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 34 (2007), 1658–1669, 10.1007/s00259-007-0454-x.
193. Santoso, S., Sachs, U.J., Kroll, H., Linder, M., Ruf, A., Preissner, K.T., Chavakis, T., The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196 (2002), 679–691, 10.1084/jem.20020267.
194. Saunders, N.R., Daneman, R., Dziegielewska, K.M., Liddelow, S.A., Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol. Asp. Med. 34 (2013), 742–752, 10.1016/j.mam.2012.11.006.
195. Savage, M.J., Iqbal, M., Loh, T., Trusko, S.P., Scott, R., Siman, R., Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience 60 (1994), 607–619, 10.1016/0306-4522(94)90490-1.
196. Savettieri, G., Di Liegro, I., Catania, C., Licata, L., Pitarresi, G.L., D'Agostino, S., Schiera, G., De Caro, V., Giandalia, G., Giannola, L.I., Cestelli, A., Neurons and ECM regulate occludin localization in brain endothelial cells. Neuroreport 11 (2000), 1081–1084, 10.1097/00001756-200004070-00035.
197. Schneeberger, E.E., Lynch, R.D., The tight junction: a multifunctional complex. Am. J. Physiol. Cell Physiol., 286, 2004, 10.1152/ajpcell.00558.2003 (C1213-C128).
198. Sengillo, J.D., Winkler, E.A., Walker, C.T., Sullivan, J.S., Johnson, M., Zlokovic, B.V., Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol. 23 (2013), 303–310, 10.1111/bpa.12004.
199. Shaw, S.K., Bamba, P.S., Perkins, B.N., Luscinskas, F.W., Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium. J. Immunol. 167 (2001), 2323–2330, 10.4049/jimmunol.167.4.2323.
200. Shechter, R., London, A., Schwartz, M., Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat. Rev. Immunol. 13 (2013), 206–218, 10.1038/nri3391.
201. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P., Rivest, S., Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49 (2006), 489–502, 10.1016/j.neuron.2006.01.022.
202. Simpson, I.A., Chundu, K.R., Davies-Hill, T., Honer, W.G., Davies, P., Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35 (1994), 546–551, 10.1016/j.neuron.2006.01.022.
203. Sixt, M., Engelhardt, B., Pausch, F., Hallmann, R., Wendler, O., Sorokin, L.M., Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J. Cell Biol. 153 (2001), 933–946, 10.1083/jcb.153.5.933.
204. Späni, C., Suter, T., Derungs, R., Ferretti, M., Welt, T., Wirth, F., Gericke, C., Nitsch, R.M., Kulic, L., Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells. Acta Neuropathol. Commun., 3, 2015, 71, 10.1186/s40478-015-0251-x.
205. Stark, K., Eckart, A., Haidari, S., Tirniceriu, A., Lorenz, M., von Brühl, M.L., Gärtner, F., Khandoga, A.G., Legate, K.R., Pless, R., Hepper, I., Lauber, K., Walzog, B., Massberg, S., Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and ‘instruct’ them with pattern-recognition and motility programs. Nat. Immunol. 14 (2013), 41–51, 10.1038/ni.2477.
206. Staykova, M., Maxwell, L., Willenborg, D., Kinetics and polarization of the membrane expression of cytokine-induced ICAM-1 on rat brain endothelial cells. J. Neuropathol. Exp. Neurol. 59 (2000), 120–128.
207. Stewart, C.R., Stuart, L.M., Wilkinson, K., van Gils, J.M., Deng, J., Halle, A., Rayner, K.J., Boyer, L., Zhong, R., Frazier, W.A., Lacy-Hulber, A., El Khoury, J., Golenbock, D.T., Moore, K.J., CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11 (2010), 155–161, 10.1038/ni.1836.
208. Stins, M.F., Gilles, F., Kim, K.S., Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76 (1997), 81–90, 10.1016/S0165-5728(97)00036-2.
209. Stomrud, E., Björkqvist, M., Janciauskiene, S., Minthon, L., Hansson, O., Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease. Alzheimers Res. Ther., 2, 2010, 20, 10.1186/alzrt44.
210. Storck, S.E., Meister, S., Nahrath, J., Meißner, J.N., Schubert, N., Di Spiezio, A., Baches, S., Vandenbroucke, R.E., Bouter, Y., Prikulis, I., Korth, C., Weggen, S., Heimann, A., Schwaninger, M., Bayer, T.A., Pietrzik, C.U., Endothelial LRP1 transports amyloid-β1-42 across the blood-brain barrier. J. Clin. Invest. 126 (2016), 123–136, 10.1172/JCI81108.
211. Sumi, N., Nishioku, T., Takata, F., Matsumoto, J., Watanabe, T., Shuto, H., Yamauchi, A., Dohgu, S., Kataoka, Y., Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cell. Mol. Neurobiol. 30 (2010), 247–253, 10.1007/s10571-009-9446-7.
212. Tietz, S., Engelhardt, B., Brain barriers: crosstalk between complex tight junctions and adherens junctions. J. Cell Biol. 209 (2015), 493–506, 10.1083/jcb.201412147.
213. Tilling, T., Korte, D., Hoheisel, D., Galla, H.J., Basement membrane proteins influence brain capillary endothelial barrier function in vitro. J. Neurochem. 71 (1998), 1151–1157, 10.1046/j.1471-4159.1998.71031151.x.
214. Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K., Kosaka, K., Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124 (2002), 83–92, 10.1016/S0165-5728(01)00496-9.
215. Town, T., Tan, J., Flavell, R.A., Mullan, M., T-cells in Alzheimer's disease. Neruomol. Med. 7 (2005), 255–264, 10.1385/NMM:7:3:255.
216. Tripathy, D., Sanchez, A., Yin, X., Luo, J., Martinez, J., Grammas, P., Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia. Front. Aging Neurosci., 5, 2013, 19, 10.3389/fnagi.2013.00019.
217. Tsukita, S., Furuse, M., Occludin and claudins in tight-junction strands: leading or supporting players?. Trends Cell Biol. 9 (1999), 268–273, 10.1016/s0962-8924(99)01578-0.
218. van Oijen, M., Witteman, J.C., Hofman, A., Koudstaal, P.J., Breteler, M.M., Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia. Stroke 36 (2005), 2637–2641, 10.1161/01.STR.0000189721.31432.26.
219. Varvel, N.H., Grathwohl, S.A., Degenhardt, K., Resch, C., Bosch, A., Jucker, M., Neher, J.J., Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's disease. J. Exp. Med. 212 (2015), 1803–1809, 10.1084/jem.20150478.
220. Verbeek, M.M., Van Nostrand, W.E., Otte-Höller, I., Wesseling, P., De Waal, R.M., Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype. Ann. N. Y. Acad. Sci. 903 (2000), 187–199, 10.1111/j.1749-6632.2000.tb06368.x.
221. Vestweber, D., How leukocytes cross the vascular endothelium. Nat. Rev. Immunol. 15 (2015), 692–704, 10.1038/nri3908.
222. Vestweber, D., Blanks, J.E., Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 79 (1999), 181–213.
223. Veszelka, S., Tóth, A.E., Walter, F.R., Datki, Z., Mózes, E., Fülöp, L., Bozsó, Z., Hellinger, E., Vastag, M., Orsolits, B., Környei, Z., Penke, B., Deli, M.A., Docosahexaenoic acid reduces amyloid-β induced toxicity in cells of the neurovascular unit. J. Alzheimers Dis. 36 (2013), 487–501, 10.3233/JAD-120163.
224. Vidal, R., Calero, M., Piccardo, P., Farlow, M.R., Unverzagt, F.W., Méndez, E., Jiménez-Huete, A., Beavis, R., Gallo, G., Gomez-Tortosa, E., Ghiso, J., Hyman, B.T., Frangione, B., Ghetti, B., Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele. Acta Neuropathol. 100 (2000), 1–12.
225. Vignini, A., Sartini, D., Morganti, S., Nanetti, L., Luzzi, S., Provinciali, L., Mazzanti, L., Emanuelli, M., Platelet amyloid precursor protein isoform expression in Alzheimer's disease: evidence for peripheral marker. Int. J. Immunopathol. Pharmacol. 24 (2011), 529–534 (SENZA DOI).
226. Vignini, A., Morganti, S., Salvolini, E., Sartini, D., Luzzi, S., Fiorini, R., Provinciali, L., Di Primio, R., Mazzanti, L., Emanuelli, M., Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study. Exp. Gerontol. 48 (2013), 1505–1508, 10.1016/j.exger.2013.10.008.
227. Viswanathan, A., Greenberg, S.M., Cerebral amyloid angiopathy in the elderly. Ann. Neurol. 70 (2011), 871–880, 10.1002/ana.22516.
228. Voisin, M.B., Woodfin, A., Nourshargh, S., Monocytes and neutrophils exhibit both distinct and common mechanisms in penetrating the vascular basement membrane in vivo. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 1193–1199, 10.1161/ATVBAHA.109.187450.
229. Vreys, V., David, G., Mammalian heparanase: what is the message?. J. Cell. Mol. Med. 11 (2007), 427–452, 10.1111/j.1582-4934.2007.00039.x.
230. Wallez, Y., Huber, P., Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim. Biophys. Acta 1778 (2008), 794–809, 10.1016/j.bbamem.2007.09.003.
231. Wan, W., Cao, L., Liu, L., Zhang, C., Kalionis, B., Tai, X., Li, Y., Xia, S., Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J. Neurochem. 134 (2015), 382–393, 10.1111/jnc.13122.
232. Wang, S., Dangerfield, J.P., Young, R.E., Nourshargh, S., PECAM-1, alpha6 integrins and neutrophil elastase cooperate in mediating neutrophil transmigration. J. Cell Sci. 118 (2005), 2067–2076.
233. Wang, H.B., Wang, J.T., Zhang, L., Geng, Z.H., Xu, W.L., Xu, T., Huo, Y., Zhu, X., Plow, E.F., Chen, M., Geng, J.G., P-selectin primes leukocyte integrin activation during inflammation. Nat. Immunol. 8 (2007), 882–892, 10.1038/ni1491.
234. Wang, Y., Jin, S., Sonobe, Y., Cheng, Y., Horiuchi, H., Parajuli, B., Kawanokuchi, J., Mizuno, T., Takeuchi, H., Suzumura, A., Interleukin-1β induces blood-brain barrier disruption by downregulating sonic hedgehog in astrocytes. PLoS One, 9, 2014, e110024, 10.1371/journal.pone.0110024.
235. Wegiel, J., Imaki, H., Wang, K.C., Wegiel, J., Rubenstein, R., Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice. Brain Res. 1022 (2004), 19–29, 10.1016/j.brainres.2004.06.058.
236. Wilhelmus, M.M., de Waal, R.M., Verbeek, M.M., Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease. Mol. Neurobiol. 35 (2007), 203–216, 10.1007/s12035-007-0029-7.
237. Wilhelmus, M.M., Otte-Höller, I., van Triel, J.J., Veerhuis, R., Maat-Schieman, M.L., Bu, G., de Waal, R.M., Verbeek, M.M., Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. Am. J. Pathol. 171 (2007), 1989–1999, 10.2353/ajpath.2007.070050.
238. Winkler, E.A., Sagare, A.P., Zlokovic, B.V., The pericyte: a forgotten cell type with important implications for Alzheimer's disease?. Brain Pathol. 24 (2014), 371–386, 10.1111/bpa.12152.
239. Winkler, E.A., Nishida, Y., Sagare, A.P., Rege, S.V., Bell, R.D., Perlmutter, D., Sengillo, J.D., Hillman, S., Kong, P., Nelson, A.R., Sullivan, J.S., Zhao, Z., Meiselman, H.J., Wenby, R.B., Soto, J., Abel, E.D., Makshanoff, J., Zuniga, E., De Vivo, D.C., Zlokovic, B.V., GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat. Neurosci. 18 (2015), 521–530, 10.1038/nn.3966.
240. Wisniewski, T., Frangione, B., Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135 (1992), 235–238, 10.1016/0304-3940(92)90444-c.
241. Wisniewski, H.M., Wegiel, J., Wang, K.C., Kujawa, M., Lach, B., Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can. J. Neurol. Sci. 16 (1989), 535–542.
242. Wolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.H., Risau, W., Engelhardt, B., Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 105 (2003), 586–592, 10.1007/s00401-003-0688-z.
243. Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R.D., Deane, R., Brooks, A.I., Kanagala, S., Rubio, A., Sagare, A., Liu, D., Li, F., Armstrong, D., Gasiewicz, T., Zidovetzki, R., Song, X., Hofman, F., Zlokovic, B.V., Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med. 11 (2005), 959–965, 10.1038/nm1287.
244. Wu, C., Ivars, F., Anderson, P., Hallmann, R., Vestweber, D., Nilsson, P., Robenek, H., Tryggvason, K., Song, J., Korpos, E., Loser, K., Beissert, S., Georges-Labouesse, E., Sorokin, L.M., Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 15 (2009), 519–527, 10.1038/nm.1957.
245. Xia, M.Q., Hyman, B.T., Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5 (1999), 32–41, 10.3109/13550289909029743.
246. Xia, M.Q., Bacskai, B.J., Knowles, R.B., Qin, S.X., Hyman, B.T., Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer's disease. J. Neuroimmunol. 108 (2000), 227–235, 10.1016/S0165-5728(00)00285-X.
247. Xiao, G., Gan, L.S., Receptor-mediated endocytosis and brain delivery of therapeutic biologics. Int. J. Cell Biol., 2013, 2013, 703545, 10.1155/2013/703545.
248. Xu, G., Zhang, H., Zhang, S., Fan, X., Liu, X., Plasma fibrinogen is associated with cognitive decline and risk for dementia in patients with mild cognitive impairment. Int. J. Clin. Pract. 62 (2008), 1070–1075, 10.1111/j.1742-1241.2007.01268.x.
249. Yadav, R., Larbi, K.Y., Young, R.E., Noursharg, S., Migration of leukocytes through the vessel wall and beyond. Thromb. Haemost. 90 (2003), 598–606.
250. Yamada, M., Itoh, Y., Shintaku, M., Kawamura, J., Jensson, O., Thorsteinsson, L., Suematsu, N., Matsushita, M., Otomo, E., Immune reactions associated with cerebral amyloid angiopathy. Stroke 27 (1996), 1155–1162.
251. Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., Schmidt, A.M., RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996), 685–691, 10.1038/382685a0.
252. Yang, Y., Rosenberg, G.A., MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Methods Mol. Biol. 762 (2011), 333–345, 10.1007/978-1-61779-185-7_24.
253. Yang, J., Lunde, L.K., Nuntagij, P., Oguchi, T., Camassa, L.M., Nilsson, L.N., Lannfelt, L., Xu, Y., Amiry-Moghaddam, M., Ottersen, O.P., Torp, R., Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease. J. Alzheimers Dis. 27 (2011), 711–722.
254. Yang, W., Wu, Q., Yuan, C., Gao, J., Xiao, M., Gu, M., Ding, J., Hu, G., Aquaporin-4 mediates astrocyte response to β-amyloid. Mol. Cell. Neurosci. 49 (2012), 406–414, 10.1016/j.mcn.2012.02.002.
255. Yang, Y.M., Shang, D.S., Zhao, W.D., Fang, W.G., Chen, Y.H., Microglial TNF-α-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration. Neurochem. Res. 38 (2013), 2295–2304, 10.1007/s11064-013-1138-5.
256. Zarbock, A., Ley, K., Mechanisms and consequences of neutrophil interaction with the endothelium. Am. J. Pathol. 172 (2008), 1–7, 10.2353/ajpath.2008.070502.
257. Zenaro, E., Pietronigro, E., Della Bianca, V., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., Montresor, A., Carlucci, T., Nanì, S., Tosadori, G., Calciano, L., Catalucci, D., Berton, G., Bonetti, B., Constantin, G., Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat. Med. 21 (2015), 880–886, 10.1038/nm.3913.
258. Zenker, D., Begley, D., Bratzke, H., Rübsamen-Waigmann, H., von Briesen, H., Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells. J. Physiol. 551 (2003), 1023–1032, 10.1113/jphysiol.2003.045880.
259. Zhang, Y.M., Zhou, Y., Qiu, L.B., Ding, G.R., Pang, X.F., Altered expression of matrix metalloproteinases and tight junction proteins in rats following PEMF­induced BBB permeability change. Biomed. Environ. Sci. 25 (2012), 197–202, 10.3967/0895-3988.2012.02.011.
260. Zipser, B.D., Johanson, C.E., Gonzalez, L., Berzin, T.M., Tavares, R., Hulette, C.M., Vitek, M.P., Hovanesian, V., Stopa, E.G., Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 28 (2007), 977–986, 10.1016/j.neurobiolaging.2006.05.016.
261. Zlokovic, B.V., Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 28 (2005), 202–208, 10.1016/j.tins.2005.02.001.
262. Zlokovic, B.V., The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008), 178–201, 10.1016/j.neuron.2008.01.003.
263. Zlokovic, B.V., Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12 (2011), 723–738, 10.1038/nrn3114.
264. Zlokovic, B.V., Deane, R., Sagare, A.P., Bell, R.D., Winkler, E.A., Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain. J. Neurochem. 115 (2010), 1077–1089, 10.1111/j.1471-4159.2010.07002.x.
265. Zuliani, G., Cavalieri, M., Galvani, M., Passaro, A., Munari, M.R., Bosi, C., Zurlo, A., Fellin, R., Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J. Neurol. Sci. 272 (2008), 164–170, 10.1016/j.jns.2008.05.020.